Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients
In conclusion, our findings show the dysregulation of miR-106a-5p-RUNX1 axis in human osteosarcoma tissues and suggest its crucial roles in cancer progression and patients' prognosis. More interestingly, miR-106a-5p may function as a tumor suppressor in osteosarcoma cells via regulating its target gene RUNX1.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Genetics | Osteosarcoma | Pathology | Statistics